I second your opinion. I also think as you do. In our
I second your opinion. I also think as you do. In our predictions of mortality on the board I used your numbers that you just stated as my prediction of mortality on the Leronlimab arm. So we have the same predicting numbers. I had the lowest of all the predictions on the board. But my numbers were the same as the anecdotal numbers by the 60 EIND’s. I never knew those numbers of saving 82% of the EIND patients until listening to the Philippines doctors and Dr. Nicholas stated those numbers 82% saved in the 60 EIND’s. I think until now we were afraid to show or talk of those type of numbers until a double blind trial could speak for us accurately. Well... now is that time. Hoping those numbers hold up as well as the anecdotal numbers. It doesn’t always happen. Prime example is Relief. Great anecdotal numbers and a wiff at the knuckle ball thrown their way. They didn’t stake their trial on mortality after their interim look. We never changed anything. That’s a huge difference. Time will tell for us. It’s my hope that we hold the same great life saving numbers.
Like many of you. I have my investment and many in my family invested and many friends and co-workers also. I have asked everyone of them to do their own due diligence and to read and understand and let’s talk about it before they invest. We are all still invested because we paid attention to the information as it was brought to light wether it be articles written or research or what doctors have said about Leronlimab. This board has been a source of great information also. There is also a lot of doubters on this board and some have reasons to doubt because they aren’t really sold on Leronlimab. For those people... I will hope they see what we all see someday and have comfort in what they do know to be true. If you have done your D&D... you know... or you think you know... if your here for any other reason then you don’t know. There is only limited time left before the first and biggest catalyst to date is either going to happen or not. There is not much time left to make those big decisions. Good luck for those that have the confidence to stay invested like myself and others. May we all feel the excitement of the first of many exciting days to come for Vyrologix. I feel good about where we are and where we are going. But that’s just the optimist in me with a lot of research to back it up. We earn our victories in life. It just takes work and belief to have them. COD is a good thing to have right now. It will get easier and less likely to have COD in the future. When all you believed is on the path you thought it would take.
10
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...
Continue Reading
Towering Goodwill Falls and Investor Scrutiny Well, let's dig into this mess ADI Global Distribution has found itself in. If you were hanging onto ADIG shares, your portfolio probably took quite the hit when they revealed a nasty $659 million goodwill write-down. Imagine opening up those financials and seeing about 62% of goodwill value wiped out overnight. Suddenly, that...
Continue Reading
New Markets Tax Credits: A Game Changer First things first, if you're thinking this is some typical charitable write-off, think again. First Horizon Bank (NYSE: FHN) is deep in the mix of something pretty transformative in the world of finance and community support. They're not just throwing money at a problem and hoping it sticks. Nope, we're talking real strategy with a...
Continue Reading
JardogsHealth: A New Chapter with Strategic Insights You've got to admire when a company rounds up a top-tier brain trust. Such is the case with JardogsHealth, the healthcare AI outfit nestled in Hillsboro, Illinois, as they align their future alongside heavyweights who’ve maneuvered through multiple industries and come out thriving. Their brand-new council includes...
Continue Reading
WhiteHorse Finance Divests Its 7.875% Notes Well, WhiteHorse Finance is making some moves, folks. They're planning to redeem their 7.875% notes due in 2028, totaling a cool $34.5 million. This ain't just pocket change, especially with the way markets have been bobbing and weaving lately. The redemption is slated for December 15, 2026, when the notes will get delisted from...
Continue Reading
Optikos Levels Up with CMMC Certification In a world where cybersecurity threats are lurking around every corner, Optikos has just joined the rarefied ranks of the top 1% of U.S. defense suppliers by grabbing the CMMC Level 2 certification. Let me tell you, this isn't just some shiny badge for show; it's a gateway to big defense contracts. Crunching the Numbers Of the...
Continue Reading
A New Chapter for Dental Tech Mark your calendars, folks. vVARDIS is stepping onto the New York Stock Exchange (NYSE) stage, waving the banner of NYSE:VVVV. Now, if you've ever sat in that squeaky dental chair feeling the dread of a drill, vVARDIS might just be the new hero in town. Founded by the dynamic duo, Dr. Haley and Dr. Goly Abivardi, they're on a mission to...
Continue Reading
Investors' Trust Shaken: The AppLovin Controversy Well, what do we have here? Another day, another hefty lawsuit coming down the pike. The spotlight’s on AppLovin Corporation (NASDAQ: APP), where the Hagens Berman law sharks are sniffing blood in the water over what they claim are federal securities law violations. The core of this legal storm swirls around AppLovin's...
Continue Reading
The Game-Changer in Virtual Production You ever hear about the Grey Box™ phenomenon? Sounds like a sci-fi gizmo, right? Turns out, it's the real deal and ACME Media's been riding this revolutionary wave straight to the top of the film industry ladder. Their approach with this AI-driven gizmo isn't just about cutting-edge tech wizardry—it's reimagining how we shoot...
Continue Reading
An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...
Continue Reading
Top 5 Most Recently Viewed Articles
Celebrating the First Direct Action Visionary Grant Recipient The American Psychological Foundation (APF) is excited to announce a groundbreaking initiative aimed at supporting communities in urgent need of psychological care. The Direct Action Visionary Grant program is designed to empower psychologists and community organizations, providing them with the necessary...
Continue Reading
Exciting New Release from Ilegal Mezcal Ilegal Mezcal is excited to unveil its latest creation, the Ilegal Reposado Caribbean Cask Finish. This limited-edition mezcal is a remarkable addition to the global mezcal landscape, showcasing a wonderful fusion of traditional craftsmanship and innovative distilling techniques. What Sets Ilegal Reposado Apart? This new offering is...
Continue Reading
NextPlat's Upcoming Financial Revelation November is shaping up to be a month of revelations for NextPlat Corp (NASDAQ:NXPL) as they prepare to spill the beans on their third-quarter 2026 financials. The number crunching wraps up at 8:30 a.m. Eastern on November 12, when the execs will host an investor conference call. The Details of the Big Day Coming to you live from...
Continue Reading
Hormel Foods Corporation Reports First Quarter Earnings Hormel Foods Corporation (NYSE: HRL) has announced its first quarter earnings, showing a mixed performance in terms of organic sales growth. While shares were trading higher before the market opened, some key metrics caught the attention of investors and analysts alike. First Quarter Adjusted Earnings Per Share The...
Continue Reading
NYAM and Yale Center on Climate Change Partnership Overview The New York Academy of Medicine (NYAM) and the Yale Center on Climate Change and Health are joining forces for an important summit focused on health systems and climate action. This event, titled 'Health Systems Implementing Climate Action 2025', promises to be a major gathering of health sector and business...
Continue Reading
